Treatment of masked depressions using bromazepam
Vencovský, E.; Peterová, E.; Soukupová, E.
Ceskoslovenska Psychiatrie 81(2): 75-78
1985
ISSN/ISBN: 0069-2336 PMID: 2861913 Document Number: 245772
Document emailed within 1 workday
Related Documents
Avrutskiĭ, G.I.; Prokhorova, I.S.; Raĭskiĭ, V.A. 1987: Role of somatic factors in the clinical picture and therapy of so-called masked depressions Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(4): 573-578Sawada, H.; Hara, A. 1978: Studies on metabolism of bromazepam. VI. Reduction of 2-(2-amino-5-bromobenzoyl)pyridine, a metabolite of bromazepam, in the rabbit, rat, and guinea pig Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(3): 205-212
Podiwinsky, F.; Jellinger, K. 1979: Bromazepam in the treatment of somatized psychogenic disorders Wiener Klinische Wochenschrift 91(7): 240-244
Smulevich, A.B.; Syrkin, A.L.; Drobizhev, M.I.; Drozdov, D.V. 1994: Alprazolam and bromazepam in the treatment of the mental disorders in patients with cardiovascular diseases Terapevticheskii Arkhiv 66(12): 26-30
Berle, J.Ø; Lund, A. 2001: Efficient treatment of depressions is possible! Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(18): 2202
Hasto, J. 1978: Sleep deprivation in the treatment of endogenous depressions Ceskoslovenska Psychiatrie 74(6): 357-364
Kielholz, P. 1975: Treatment for masked depression Psychopharmacology Bulletin 11(1): 31-34
Voss, A.; Kind, H. 1974: Outpatient treatment of endogenous depressions by sleep deprivation Schweizerische Rundschau für Medizin Praxis 63(18): 564-565
Koracević, L.G.; Stojanović, M.; Lović, D. 2019: Is there an unrecognized type of masked hypertension - "weekend masked hypertension"? Journal of Biological Regulators and Homeostatic Agents 33(1): 187-189
Demling, J. 1991: Antidepressive agents in the treatment of masked moods Fortschritte der Medizin 109(27): 540-544
Dubnitskaia, E.B. 1997: The importance of the correct diagnosis and treatment of depressions in general medical practice Terapevticheskii Arkhiv 69(5): 84-85
Gorbunov, V.M.; Smirnova, G.F.; Andreeva, G.F.; Deev, A.D.; Shal'nova, S.A. 2009: Prevalence and predictors of masked inefficacy of treatment of arterial hypertension during use of various groups of antihypertensive drugs Kardiologiia 49(2): 32-37
Mel'nikova, T.S.; Podzolkov, V.I. 1990: Cranial electric stimulation in the treatment of patients with initial stages of hypertension and signs of masked depression Klinicheskaia Meditsina 68(9): 37-39
Amphoux, G.; Agussol, P.; Girard, J. 1982: The action of bromazepam on anxiety La Nouvelle Presse Medicale 11(22): 1738-1740
Kress, J.J.; Maheo, M.; Cledes, A.; Chastaing, A.; Conan, P. 1982: Clinical trial of bromazepam in hospital psychiatry La Nouvelle Presse Medicale 11(22): 1735-1737
Kambara, N.; Kitamura, S.; Taniguchi, A.; Hamao, W.; Matsuyama, M. 1995: Premedication in children: a comparison of oral midazolam and rectal bromazepam Masui. Japanese Journal of Anesthesiology 44(12): 1707-1711
Zapletálek, M.; Kudrnová, K.; Preiningerová, O.; Zapletálková, J. 1982: Comparison of the therapeutic effect of bromazepam and chlorprothixene in depressive neuroses Ceskoslovenska Psychiatrie 78(6): 375-381
Siurala, M. 1980: The possible significance of the central action of trimipramine in the treatment of functional "non-ulcer" dyspepsia, and peptic ulcer with masked depression Scandinavian Journal of Gastroenterology. Suppl 58: 57-58
Nakamura, K.; Hayashi, T.; Nakamura, K. 1984: Effects of bromazepam on cerebral neuronal activity in male Wistar rats with immobilized stress Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(5): 401-412
Montenegro, M.; Veiga, H.; Deslandes, Aéa.; Cagy, Mício.; McDowell, K.; Pompeu, F.; Piedade, R.; Ribeiro, P. 2005: Neuromodulatory effects of caffeine and bromazepam on visual event-related potential (P300): a comparative study Arquivos de Neuro-Psiquiatria 63(2b): 410-415